Beam Therapeutics (BEAM) Insider Trading & Ownership $21.54 +0.51 (+2.43%) Closing price 04:00 PM EasternExtended Trading$21.51 -0.03 (-0.13%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Beam Therapeutics (NASDAQ:BEAM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$5.84M Get BEAM Insider Trade Alerts Want to know when executives and insiders are buying or selling Beam Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BEAM Insider Buying and Selling by Quarter Beam Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/3/2025Amy SimonInsiderSell876$20.12$17,625.12 7/1/2025Amy SimonInsiderSell374$16.94$6,335.56 4/1/2025Christine BellonInsiderSell5,674$18.35$104,117.90 4/1/2025Giuseppe CiaramellaPresidentSell7,434$18.35$136,413.90 4/1/2025John M EvansCEOSell30,663$18.35$562,666.05 1/30/2025John M EvansCEOSell30,000$26.75$802,500.00 1/2/2025Christine BellonInsiderSell1,241$24.68$30,627.88 11/6/2024Giuseppe CiaramellaPresidentSell51,110$26.36$1,347,259.60 10/14/2024Giuseppe CiaramellaPresidentSell51,110$26.27$1,342,659.70 10/1/2024Bethany J CavanaghSVPSell289$23.48$6,785.72 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/1/2024Christine BellonInsiderSell385$23.48$9,039.80 9/30/2024John M EvansCEOSell60,000$24.60$1,476,000.00 (Data available from 1/1/2013 forward) BEAM Insider Trading Activity - Frequently Asked Questions Who is on Beam Therapeutics' Insider Roster? The list of insiders at Beam Therapeutics includes Amy Simon, Bethany J Cavanagh, Christine Bellon, Fmr Llc, Giuseppe Ciaramella, John M Evans, and Terry-Ann Burrell. Learn more on insiders at BEAM. What percentage of Beam Therapeutics stock is owned by insiders? 3.50% of Beam Therapeutics stock is owned by insiders. Learn more on BEAM's insider holdings. Which Beam Therapeutics insiders have been selling company stock? The following insiders have sold BEAM shares in the last 24 months: Amy Simon ($330,320.21), Bethany J Cavanagh ($6,785.72), Christine Bellon ($203,034.32), Fmr Llc ($48,139.40), Giuseppe Ciaramella ($3,010,569.34), John M Evans ($8,444,183.31), and Terry-Ann Burrell ($174,925.52). How much insider selling is happening at Beam Therapeutics? Insiders have sold a total of 463,411 Beam Therapeutics shares in the last 24 months for a total of $12,217,957.82 sold. Beam Therapeutics Key ExecutivesMr. John M. Evans M.B.A. (Age 46)CEO & Director Compensation: $1.13M2 recent tradesDr. Giuseppe Ciaramella Ph.D. (Age 55)President Compensation: $955.55kDr. Christine P. Bellon J.D. (Age 58)Ph.D., Senior VP, Chief Legal Officer & Corporate Secretary Compensation: $680.08kDr. Amy Simon M.D. (Age 60)Chief Medical Officer Compensation: $715.58kDr. Feng Zhang Ph.D.Co-FounderDr. David R. Liu Ph.D.Co-FounderDr. J. Keith Joung M.D.Ph.D., Co-FounderDr. Manmohan Singh Ph.D.Chief Technology OfficerDr. Gopi Shanker Ph.D.Chief Scientific OfficerMs. Susan O'Connor (Age 60)Chief Human Resources Officer More Insider Trading Tools from MarketBeat Related Companies CRISPR Therapeutics Insider Transactions Denali Therapeutics Insider Transactions Editas Medicine Insider Transactions Intellia Therapeutics Insider Transactions Twist Bioscience Insider Transactions Veracyte Insider Transactions Blueprint Medicines Insider Transactions Roivant Sciences Insider Transactions Elanco Animal Health Insider Transactions Revolution Medicines Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealth This page (NASDAQ:BEAM) was last updated on 7/22/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beam Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.